CALIFORNIA | TECHNOLOGY / PEOPLE. AI Is Leaving the Computer and Entering the Laboratory

Anthropic has quietly built a biology lab in the San Francisco Bay Area. The bigger story isn't simply that an AI company owns a laboratory. It's what happens when artificial intelligence begins moving from analyzing experiments to helping conduct them.

By BDZ News Desk

Published September 20, 2026

For most people, artificial intelligence still lives behind a screen.

You ask a question. It writes an email. It creates an image. It analyzes a document.

But in California, AI is beginning to cross a much more consequential boundary.

It's entering the physical laboratory.

Anthropic, the company behind Claude, has established a wet lab in the San Francisco Bay Area where it is conducting real biological experiments, the company's head of life sciences confirmed to Reuters.

A wet lab is exactly what the name suggests: a laboratory where researchers physically work with biological or chemical materials rather than limiting their research to computer simulations.

And Anthropic wants AI to play an increasingly important role inside it.

From Answering Questions to Running Experiments

Anthropic's ambitions go beyond asking Claude to read research papers or analyze scientific data.

The company is exploring ways for its AI to direct robotic laboratory equipment and automate portions of scientific experiments, according to Reuters. Anthropic says human involvement and oversight remain essential.

That could eventually create a very different kind of laboratory.

Imagine an AI system analyzing thousands of scientific papers, proposing an experiment, coordinating laboratory equipment, reviewing the results and then using those results to determine what experiment should come next.

Parts of that vision are already beginning to take shape.

In August, Anthropic introduced its Model Hardware Standard, technology designed to allow AI agents to operate physical equipment including microscopes, liquid handlers and robotic arms. The company says the system can coordinate multiple pieces of equipment and adjust parameters during experiments.

Anthropic says the technology could eventually help laboratories operate automated experiments around the clock.

That's a significant leap from the chatbot most people recognize as AI.

Why Biology?

Modern biological research involves an enormous amount of information.

Researchers work across scientific papers, genetic databases, protein structures, chemical information, and experimental results.

Finding useful connections across it all can take enormous amounts of human time.

That's precisely the kind of problem AI companies believe their systems can help solve.

Earlier this year, Anthropic introduced Claude Science, a research environment designed to help scientists work across scientific databases and tools used in fields including genomics, proteomics, structural biology and cheminformatics.

Now the company is moving beyond the digital side of that process.

Anthropic's life sciences chief, Eric Kauderer-Abrams, told Reuters that eventually biology still has to confront the physical world.

“The final test is still and will be for a while in real lab work.” 

In other words, an AI can generate a promising scientific idea.

But eventually somebody, or something, must test whether it actually works.

The Hope: Discovering Medicines Faster

One of the most ambitious possibilities is medicine.

Anthropic has said it wants to explore treatments for rare diseases and conditions that traditional pharmaceutical companies may have less financial incentive to pursue. The company has discussed using AI for preclinical research while leaving clinical trials and bringing drugs to market to established pharmaceutical and biotechnology companies.

There is an important distinction here.

Anthropic says its new laboratory is not specifically a drug-discovery lab.

The company has not publicly disclosed exactly what experiments are taking place there.

And even if AI dramatically accelerates the earliest stages of drug research, that does not mean new medicines will suddenly appear at pharmacies.

Potential drugs still face extensive laboratory testing, clinical trials and regulatory review. Many experimental medicines never make it through that process.

But shortening the research that happens before those stages could still matter.

A Laboratory That Never Sleeps?

The potentially transformative part of this story isn't simply AI becoming smarter.

It's AI gaining the ability to interact with physical machines.

Anthropic says its Model Hardware Standard can connect AI agents with laboratory and manufacturing equipment. In its research preview, the company described systems that can reason through experimental steps, adjust parameters, and, in some cases, recover from hardware errors.

That could eventually let researchers automate repetitive experiments that currently require significant human labor.

A scientist could design the broader research strategy while automated systems perform portions of the experimentation.

Experiments could potentially run overnight.

Thousands of variations could be tested.

Failed experiments could produce data that informs the next attempt.

The researcher doesn't necessarily disappear.

The research cycle gets faster.

At least, that's the promise.

Then Comes the Uncomfortable Question

Giving increasingly capable AI systems access to biological research also creates obvious concerns.

The same technology that can help scientists understand biology can potentially be misused.

Anthropic acknowledged that problem just days before news of its laboratory became public.

On September 17, the company introduced a Life Sciences Verification Program that gives vetted researchers greater access to advanced AI capabilities for legitimate biological work while applying additional screening to potentially higher-risk research.

Anthropic says applicants can be evaluated based on research credentials, security standards and ethical oversight.

The company also acknowledges that distinguishing legitimate biological research from potentially dangerous misuse can sometimes be difficult because similar scientific knowledge can have beneficial and harmful applications.

That creates a tension likely to follow AI deeper into science.

The more useful these systems become to legitimate researchers, the more capable they may also become of providing knowledge that requires careful controls.

Anthropic says human oversight remains essential as it experiments with greater laboratory automation.

This Is Bigger Than One Laboratory

Anthropic isn't the only company betting that AI can transform science.

Artificial intelligence is already being applied across biotechnology, pharmaceutical research and protein modeling.

But putting AI together with laboratory robotics represents another step.

For years, we've talked about AI primarily as something that works with information.

Words.

Images.

Numbers.

Code.

Scientific papers.

Now we're beginning to see AI connected to machines capable of interacting with the physical world.

Microscopes.

Robotic arms.

Laboratory instruments.

Biological experiments.

And that changes the conversation.

The question is no longer simply:

What can AI tell us?

Increasingly, the question may become:

What can AI actually do?